TORONTO, Dec. 15, 2016 /CNW/ - Birch Hill Equity Partners Management Inc. ("Birch Hill"), as general partner of each of Birch Hill Equity Partners III, LP, Birch Hill Equity Partners (SC) III, LP, Birch Hill Equity Partners (US) III, LP and Birch Hill Equity Partners (Entrepreneurs) III, LP announced today that it holds no issued and outstanding common shares of BIOX Corporation (TSX: BX) (the "Issuer").
On December 15, 2016 Birch Hill sold 7,475,000 common shares (the "Shares") of the Issuer, representing approximately 16.2% of the issued and outstanding common shares of the Issuer, in a private transaction with FP Resources Limited. The Shares were sold for cash consideration of $0.89788 per Share for an aggregate cash consideration of $6,711,687.50.
An early warning report will be electronically filed with the applicable securities commission in each jurisdiction where the Issuer is reporting and will be available on SEDAR at www.sedar.com.
Birch Hill Equity Partners Management Inc.
100 Wellington Street West
Suite 2300, TD West Tower
P.O. Box 22
Toronto, ON M5K 1A1
SOURCE Birch Hill Equity Partners Management Inc.
For further information: or to obtain a copy of the early warning report, please contact Michael Salamon at (416) 775-3812